Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation

British Journal of Pharmacology

Volumn 171, Issue 9, 2014, Pages 2426-2439

  Hassan, Samia ^a   Eldeeb, Khalil ^a,b   Millns, Paul J ^a   Bennett, Andrew J ^a   Alexander, Stephen P H ^a   Kendall, David A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

calcium influx; cannabidiol; cannabinoid; microglia; phagocytosis

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; CALCIUM ION; CANNABIDIOL; CAPSAZEPINE; EGTAZIC ACID; N (1,4 BENZODIOXAN 6 YL) 3 (4 TERT BUTYLPHENYL)ACRYLAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; RUTHENIUM RED; TRANSIENT RECEPTOR POTENTIAL CHANNEL; WORTMANNIN; CALCIUM CHANNEL; TRPV1 PROTEIN, MOUSE; TRPV2 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; DRUG MECHANISM; FLUORESCENCE ANALYSIS; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALE; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; SINGLE CELL ANALYSIS; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CALCIUM CHANNELS; CANNABIDIOL; CELLS, CULTURED; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; PHAGOCYTOSIS; TRPV CATION CHANNELS;

EID: 84898662031     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12615     Document Type: Article

References (38)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013) the Concise Guide to PHARMACOLOGY 2013/14: Ion Channels. Br J Pharmacol 170: 1607-1651.
2. Aoyagi K, Ohara-Imaizumi M, Nishiwaki C, Nakamichi Y, Nagamatsu S, (2010). Insulin/phosphoinositide 3-kinase pathway accelerates the glucose-induced first-phase insulin secretion through TrpV2 recruitment in pancreatic beta-cells. Biochem J 432: 375-386.
3. Bang S, Kim KY, Yoo S, Lee SH, Hwang SW, (2007). Transient receptor potential V2 expressed in sensory neurons is activated by probenecid. Neurosci Lett 425: 120-125. (Pubitemid 47410367)
4. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, et al. (2000). Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6: 916-919. (Pubitemid 30644751)
5. Barichello T, Ceretta RA, Generoso JS, Moreira AP, Simoes LR, Comim CM, et al. (2012). Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis. Eur J Pharmacol 697: 158-164.
6. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, et al. (2001). Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134: 845-852. (Pubitemid 33016156)
7. Bomben VC, Sontheimer HW, (2008). Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas. Cell Prolif 41: 98-121.
8. Cao H, Zhang YQ, (2008). Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev 32: 972-983.
9. De Petrocellis L, Ligresti A, Moriello AS, Allara M, Bisogno T, Petrosino S, et al. (2011). Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol 163: 1479-1494.
10. De Petrocellis L, Orlando P, Moriello AS, Aviello G, Stott C, Izzo AA, et al. (2012). Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol (Oxf) 204: 255-266.
11. 2+ elevations in hippocampal cells. Neuropharmacology 50: 621-631.
12. Franklin A, Stella N, (2003). Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol- sensitive receptors. Eur J Pharmacol 474: 195-198. (Pubitemid 37281448)
13. Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, et al. (2005). AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 313: 474-484. (Pubitemid 40411374)
14. Hisanaga E, Nagasawa M, Ueki K, Kulkarni RN, Mori M, Kojima I, (2009). Regulation of calcium-permeable TRPV2 channel by insulin in pancreatic beta-cells. Diabetes 58: 174-184.
15. Izzo AA, Borrelli F, Capasso R, Di M V, Mechoulam R, (2009). Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30: 515-527.
16. Juknat A, Rimmerman N, Levy R, Vogel Z, Kozela E, (2012). Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells. Neurochem Int 61: 923-930.
17. Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, Kim WB, et al. (1999). Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 19: 529-538. (Pubitemid 29036004)
18. Kanzaki M, Zhang YQ, Mashima H, Li L, Shibata H, Kojima I, (1999). Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I. Nat Cell Biol 1: 165-170. (Pubitemid 129656021)
19. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A, (2011). Physiology of microglia. Physiol Rev 91: 461-553.
20. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
21. Kim SJ, Kim YS, Yuan JP, Petralia RS, Worley PF, Linden DJ, (2003). Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1. Nature 426: 285-291. (Pubitemid 37463146)
22. Kozela E, Pietr M, Juknat A, Rimmerman N, Levy R, Vogel Z, (2010). Cannabinoids delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells. J Biol Chem 285: 1616-1626.
23. Lawson LJ, Perry VH, Dri P, Gordon S, (1990). Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39: 151-170.
24. Link TM, Park U, Vonakis BM, Raben DM, Soloski MJ, Caterina MJ, (2010). TRPV2 has a pivotal role in macrophage particle binding and phagocytosis. Nat Immunol 11: 232-239.
25. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
26. Martin-Moreno AM, Reigada D, Ramirez BG, Mechoulam R, Innamorato N, Cuadrado A, et al. (2011). Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Mol Pharmacol 79: 964-973.
27. Mecha M, Torrao AS, Mestre L, Carrillo-Salinas FJ, Mechoulam R, Guaza C, (2012). Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress. Cell Death Dis 3: e331.
28. Mechoulam R, Parker LA, Gallily R, (2002). Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 42: 11S-19S. (Pubitemid 35205041)
29. Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO, (2007). Cannabidiol-recent advances. Chem Biodivers 4: 1678-1692. (Pubitemid 47377200)
30. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, et al. (1990). SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 271: 515-522. (Pubitemid 20344770)
31. Minghetti L, Levi G, (1998). Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 54: 99-125. (Pubitemid 28049822)
32. Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T, (2007). Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362: 928-934. (Pubitemid 47390663)
33. Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, Flores CM, (2008). TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci 28: 6231-6238.
34. Robbins N, Koch SE, Tranter M, Rubinstein J, (2012) the history and future of probenecid. Cardiovasc Toxicol 2: 1-9.
35. Ross RA, (2003). Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol 140: 790-801. (Pubitemid 37464060)
36. Sagar DR, Burston JJ, Hathway GJ, Woodhams SG, Pearson RG, Bennett AJ, et al. (2011) the contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain. Mol Pain 7: 88.
37. Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE, (2006). Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol 128: 509-522. (Pubitemid 44664629)
38. Woodroofe MN, Sarna GS, Wadhwa M, Hayes GM, Loughlin AJ, Tinker A, et al. (1991). Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol 33: 227-236.